No Data
No Data
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Soars on Dermatological Treatments Launch
New Forecasts: Here's What Analysts Think The Future Holds For Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Celebrations may be in order for Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company. The revenu
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
Arcutis Biotherapeutics(ARQT.US) Officer Sells US$68,581.99 in Common Stock
$Arcutis Biotherapeutics(ARQT.US)$ Officer Edwards Larry Todd sold 7,640 shares of common stock on May 17, 2024 at an average price of $8.9767 for a total value of $68,581.99.Source: Announcement What
Wall Street Analysts Believe Arcutis Biotherapeutics (ARQT) Could Rally 101.09%: Here's Is How to Trade
No Data